NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Stock Overview
Europe - BIT:1NBIX - US64125C1099 - Common Stock
1NBIX.MI Key Statistics, Chart & Performance
The current stock price of 1NBIX.MI is 120.05 EUR.
1NBIX.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 21.68 | 347.31B | ||
| 1ABBV.MI | ABBVIE INC | 21.48 | 344.13B | ||
| AMG.DE | AMGEN INC | 13.5 | 135.69B | ||
| GIS.DE | GILEAD SCIENCES INC | 15.7 | 129.19B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 24.43 | 90.83B | ||
| ARGX.BR | ARGENX SE | 96.19 | 43.82B | ||
| 1AE.DE | ARGENX SE | 96.11 | 43.79B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.56B | ||
| IDP.DE | BIOGEN INC | 8.98 | 18.04B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.86B | ||
| 0QF.DE | MODERNA INC | N/A | 8.85B | ||
| 2X1.DE | ABIVAX SA | N/A | 6.40B |
Related stock screener links
About 1NBIX.MI
Company Profile
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company is headquartered in San Diego, California and currently employs 1,800 full-time employees. The firm is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa, and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.
Company Info
NEUROCRINE BIOSCIENCES INC
6027 Edgewood Bend Court
San Diego CALIFORNIA US
Employees: 1800
Phone: 18586177600
NEUROCRINE BIOSCIENCES INC / 1NBIX.MI FAQ
What is the stock price of NEUROCRINE BIOSCIENCES INC today?
The current stock price of 1NBIX.MI is 120.05 EUR.
What is the ticker symbol for NEUROCRINE BIOSCIENCES INC stock?
The exchange symbol of NEUROCRINE BIOSCIENCES INC is 1NBIX and it is listed on the Euronext Milan exchange.
On which exchange is 1NBIX.MI stock listed?
1NBIX.MI stock is listed on the Euronext Milan exchange.
What is NEUROCRINE BIOSCIENCES INC worth?
NEUROCRINE BIOSCIENCES INC (1NBIX.MI) has a market capitalization of 11.91B EUR. This makes 1NBIX.MI a Large Cap stock.
How many employees does NEUROCRINE BIOSCIENCES INC have?
NEUROCRINE BIOSCIENCES INC (1NBIX.MI) currently has 1800 employees.
Is NEUROCRINE BIOSCIENCES INC (1NBIX.MI) expected to grow?
The Revenue of NEUROCRINE BIOSCIENCES INC (1NBIX.MI) is expected to grow by 18.64% in the next year. Check the estimates tab for more information on the 1NBIX.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEUROCRINE BIOSCIENCES INC (1NBIX.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 1NBIX.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 1NBIX.MI, evaluating the profitability, health, valuation and growth aspects
- NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Sales and EPS estimates to see what analysts future expectations are.
- NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Stock Chart to make your own analysis
- NEUROCRINE BIOSCIENCES INC (1NBIX.MI) Latest news and press-releases to stay up to date.
Does NEUROCRINE BIOSCIENCES INC (1NBIX.MI) stock pay dividends?
1NBIX.MI does not pay a dividend.
When does NEUROCRINE BIOSCIENCES INC (1NBIX.MI) report earnings?
NEUROCRINE BIOSCIENCES INC (1NBIX.MI) will report earnings on 2025-10-28, before the market open.
What is the Price/Earnings (PE) ratio of NEUROCRINE BIOSCIENCES INC (1NBIX.MI)?
The PE ratio for NEUROCRINE BIOSCIENCES INC (1NBIX.MI) is 41.54. This is based on the reported non-GAAP earnings per share of 2.89 and the current share price of 120.05 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1NBIX.MI.
1NBIX.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1NBIX.MI.
1NBIX.MI Financial Highlights
Over the last trailing twelve months 1NBIX.MI reported a non-GAAP Earnings per Share(EPS) of 2.89. The EPS increased by 2.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.88% | ||
| ROA | 8.95% | ||
| ROE | 12.93% | ||
| Debt/Equity | 0 |
1NBIX.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of 37.76% and a revenue growth 18.64% for 1NBIX.MI